AP Syllabus focus:
‘The ligand-binding domain of a receptor recognizes specific messengers; receptors may be at the surface, in the cytoplasm, or in the nucleus.’
Cells detect signals using receptor proteins whose structures determine what they can “hear” and where they can respond. Understanding ligand-binding domains links molecular shape to signalling specificity, location, and downstream cellular changes.
Receptors and ligand-binding domains: core ideas
Receptors are proteins that bind specific chemical messengers (ligands) and convert that binding event into a cellular effect. The most important feature for specificity is the ligand-binding domain, whose shape and chemistry match particular ligands.
Practice Questions
FAQ
They often use the dissociation constant, $K_d$, derived from binding equilibrium measurements.
Lower $K_d$ indicates higher affinity. Techniques include radioligand binding assays and surface plasmon resonance.
Yes. Some receptors show “promiscuity,” binding multiple related ligands with different affinities.
Different ligands can stabilise different receptor conformations, leading to biased or partial activation.
An allosteric modulator binds at a site other than the primary ligand-binding domain.
This changes the receptor’s shape and can increase or decrease the primary ligand’s binding or the receptor’s activation.
Protein targeting signals and trafficking pathways direct receptors. For example:
Signal peptides and transmembrane segments aid membrane insertion
Nuclear localisation signals promote import into the nucleus
Mis-targeting can disrupt signalling even if ligand binding is normal.
They can evolve under selection to recognise new ligands or avoid inappropriate activation.
Gene duplication followed by mutation can produce receptor families with diversified binding pockets and affinities.
